EU bans 700 generic drugs for manipulation of trials by GVK
The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences.
Jul 25, 2015, 14:26 PM ISTGlenmark's subsidiary to pay $25 mn to settle a pricing case
Pharmaceutical major Glenmark on Wednesday said its US subsidiary will pay USD 25 million to the federal government there as well as to the Texas state administration to settle a pricing investigation.
Apr 08, 2015, 13:14 PM IST